Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human NR0B2 Antibodies:
anti-Mouse (Murine) NR0B2 Antibodies:
anti-Rat (Rattus) NR0B2 Antibodies:
Go to our pre-filtered search.
Human Polyclonal NR0B2 Primary Antibody for EIA, IF - ABIN953745
Zhou, Zhang, Macchiarulo, Yang, Cellanetti, Coto, Xu, Pellicciari, Wang: Novel polymorphisms of nuclear receptor SHP associated with functional and structural changes. in The Journal of biological chemistry 2010
Show all 5 references for ABIN953745
Cow (Bovine) Polyclonal NR0B2 Primary Antibody for WB - ABIN2774985
Park, Park, An, Choi, Kim, Cheong, Yang: Bile acid regulates c-Jun expression through the orphan nuclear receptor SHP induction in gastric cells. in Biochemical and biophysical research communications 2008
The finding that overexpression of HIF-1alpha (show HIF1A Antibodies) increased the activity of the CYP7A1 (show CYP7A1 Antibodies) promoter suggested that hypoxia decreased the expression of CYP7A1 (show CYP7A1 Antibodies) in a HIF-1 (show HIF1A Antibodies)-independent manner.
Results demonstrated a detrimental effect of Bcl2 (show BCL2 Antibodies) and H19 (show NCKAP1 Antibodies) associated with cholestatic liver fibrosis and an indispensable role of Shp (show LAMC1 Antibodies) to maintain normal liver function.
These findings show that POD-1/TCF21 (show TCF21 Antibodies) regulates SF-1 (show NR5A1 Antibodies) and LRH-1 (show NR5A2 Antibodies) by distinct mechanisms, contributing to the understanding of POD-1 (show TCF21 Antibodies) involvement and its mechanisms of action in adrenal and liver tumorigenesis.
Overexpression of SHP (show LAMC1 Antibodies) and activation of AMPK (show PRKAA1 Antibodies) reverses profibrogenic features of HCV-infected cells by decreasing TGF-beta (show TGFB1 Antibodies) and fibrotic gene expression.
Data suggest that LRH1/NR5A2 (show NR5A2 Antibodies) (liver receptor homologue-1) exhibits phospholipid-mediated allosteric control of protein-protein binding interface in interactions with TIF2 (show NCOA2 Antibodies) (co-activator; transcription intermediary factor 2) and SHP (show LAMC1 Antibodies).
At the molecular level, estrogen upregulated hepatic SHP (show LAMC1 Antibodies) expression through binding to its proximal promoter. In addition, the roles of estrogen were largely blunted in mice with SHP (show LAMC1 Antibodies) deficiency.
These data are suggestive of a role for SHP (show LAMC1 Antibodies) in controlling NLRP3 (show NLRP3 Antibodies) inflammasome activation through a mechanism involving interaction with NLRP3 (show NLRP3 Antibodies) and maintenance of mitochondrial homeostasis.
These results establish SHP (show LAMC1 Antibodies) as a novel antihypertrophic regulator that acts by interfering with GATA6 (show GATA6 Antibodies) signaling.
E2F1 transcription factor (show E2F1 Antibodies) activates early growth response (Egr)-1 (show EGR1 Antibodies) promoter which is repressed by SHP (show LAMC1 Antibodies) and EIA-like inhibitor of differentiation (EID)1 (show EID1 Antibodies).
SHP (show LAMC1 Antibodies) regulates PDCD5 (show PDCD5 Antibodies)-mediated apoptosis in cancer cells
Six novel SNPs, five in ME1 (show ME1 Antibodies) and one in NR0B2, were identified as candidates that have effects on meat and carcass quality traits.
This study reveals SHP (show LAMC1 Antibodies) as a global transcriptional partner of SREBP-2 (show SREBF2 Antibodies) in regulation of sterol biosynthetic gene networks and provides a potential mechanism for cholesterol-lowering action of FGF19 (show FGF19 Antibodies).
Our results suggest that SHP (show LAMC1 Antibodies) is required for both antidiabetic and hypolipidemic effects of TZDs in ob/ob mice through regulation of PPARgamma (show PPARG Antibodies) expression.
LSD1 (show KDM1A Antibodies) is a novel histone-modifying enzyme in the orchestrated regulation mediated by the farnesoid X receptor (show xpr1 Antibodies) and small heterodimer partner that reduces hepatic bile acid levels and protects the liver against bile acid toxicity.
SHP (show LAMC1 Antibodies) ablation creates a proinflammatory phenotype which is exacerbated after sleeve gastrectomy despite weight loss. These inflammatory alterations are possibly related to factors extrinsic to a direct manifestation of Non-alcoholic fatty liver.
Data indicate that EE2-induced cholestasis increases SHP (show LAMC1 Antibodies) and represses CYP2D6 (show CYP2D6 Antibodies) expression in Tg-CYP2D6 (show CYP2D6 Antibodies) mice in part through ERa transactivation of Shp (show LAMC1 Antibodies) promoter.
Neonatal exposure to diethylstilbestrol alters adult hepatic physiology in an SHP (show LAMC1 Antibodies)-dependent manner.
Disruption of Shp (show LAMC1 Antibodies) in mice alters timing of expression of genes that regulate homocysteine metabolism and the liver responses to ethanol and homocysteine. SHP (show LAMC1 Antibodies) inhibits the transcriptional activation of Bhmt (show BHMT Antibodies) and cystathionine gamma-lyase (show CTH Antibodies) by FOXA1 (show FOXA1 Antibodies).
Shp (show LAMC1 Antibodies) and Npas2 (show NPAS2 Antibodies) crosstalk is essential to maintain hepatic lipid homeostasis.
The protein encoded by this gene is an unusual orphan receptor that contains a putative ligand-binding domain but lacks a conventional DNA-binding domain. The gene product is a member of the nuclear hormone receptor family, a group of transcription factors regulated by small hydrophobic hormones, a subset of which do not have known ligands and are referred to as orphan nuclear receptors. The protein has been shown to interact with retinoid and thyroid hormone receptors, inhibiting their ligand-dependent transcriptional activation. In addition, interaction with estrogen receptors has been demonstrated, leading to inhibition of function. Studies suggest that the protein represses nuclear hormone receptor-mediated transactivation via two separate steps: competition with coactivators and the direct effects of its transcriptional repressor function.
short heterodimer partner
, nuclear receptor subfamily 0 group B member 2
, nuclear receptor SHP
, orphan nuclear receptor SHP
, small heterodimer partner
, small heterodimer partner homologue